Daiichi Sankyo
Caleb Lee is an accomplished executive in the pharmaceutical industry, currently serving as Executive Director at Daiichi Sankyo US since July 2016, with previous roles including Senior Director, Director, and Associate Director in Global Oncology R&D. Prior to this, Caleb completed a fellowship in Hematology/Oncology at Mt Sinai Hospital Medical Center from July 2010 to June 2016 and served as an Internal Medicine Resident at the Icahn School of Medicine at Mount Sinai from July 2008 to June 2010. Educational credentials include an MD/PhD in Immunology from Tufts University School of Medicine, earned between 1999 and 2008, and a Bachelor of Arts in Biology from Harvard University, obtained from 1995 to 1998.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.